Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.57 |
| ▸ | ELANE | P08246 | 2/20 | 0.37 |
| ▸ | CTSG | P08311 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.30 |
| ▸ | CCND1 | P24385 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3173883 | 0.89 | GABRA1 (0.48) | GABRA1GABRB2ELANECTSG | |
| SCHEMBL3258418 | 0.85 | GABRA1 (0.55) | GABRA1GABRB2 | |
| SCHEMBL3261080 | 0.83 | GABRA1 (0.44) | GABRA1GABRB2 | |
| SCHEMBL3258406 | 0.81 | GABRA1 (0.42) | GABRA1GABRB2ELANECTSG | |
| SCHEMBL3261977 | 0.81 | ALDH1A1 (0.39) | GABRA1GABRB2 | |
| SCHEMBL3259025 | 0.77 | PTPN1 (0.39) | ELANECTSG | |
| SCHEMBL3259308 | 0.77 | CA2 (0.44) | GABRA1GABRB2 | |
| SCHEMBL864085 | 0.76 | GABRA1 (1.00) | GABRA1GABRB2ELANECTSGCDK1 | |
| SCHEMBL17942366 | 0.74 | GABRA1 (0.67) | GABRA1GABRB2ELANECTSG | |
| SCHEMBL3190724 | 0.73 | HPGD (0.37) | GABRA1GABRB2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8952189-B2 | Process for preparing diaryl carbonates or alkyl aryl carbonates from dialkyl carbonates | BAYER MATERIALSCIENCE AG (DE) | 2015-02-10 | — | — | US | disclosed |
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | BAYER MATERIALSCIENCE AG (DE) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261928-A1 | PROCESS FOR PREPARING DIARYL CARBONATES OR ALKYL ARYL CARBONATES FROM DIALKYL CARBONATES | HDHD5, AHR, AGL | GABRA1 3932/4885GABRB2 4443/4885ELANE 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.